Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · IEX Real-Time Price · USD
0.293
-0.022 (-6.90%)
At close: Jul 19, 2024, 4:00 PM
0.279
-0.014 (-4.88%)
Pre-market: Jul 22, 2024, 7:40 AM EDT
Qualigen Therapeutics Market Cap
Qualigen Therapeutics has a market cap or net worth of $3.33 million as of July 22, 2024. Its market cap has decreased by -29.09% in one year.
Market Cap
3.33M
Enterprise Value
4.26M
1-Year Change
-29.09%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since June 24, 2015, Qualigen Therapeutics's market cap has decreased from $38.60M to $3.33M, a decrease of -91.37%. That is a compound annual growth rate of -23.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.80M | - |
| Dec 29, 2023 | 2.80M | -48.15% |
| Dec 30, 2022 | 5.40M | -82.69% |
| Dec 31, 2021 | 31.20M | -55.04% |
| Dec 31, 2020 | 69.40M | 3,982.35% |
| Dec 31, 2019 | 1.70M | -50.00% |
| Dec 31, 2018 | 3.40M | -79.14% |
| Dec 29, 2017 | 16.30M | -43.99% |
| Dec 30, 2016 | 29.10M | 120.45% |
| Dec 31, 2015 | 13.20M | -65.80% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Applied DNA Sciences | 3.63M |
| Avinger | 3.58M |
| Lipella Pharmaceuticals | 3.48M |
| Xylo Technologies | 3.41M |
| Aptevo Therapeutics | 3.39M |
| 60 Degrees Pharmaceuticals | 3.31M |
| Ensysce Biosciences | 3.30M |
| ZyVersa Therapeutics | 3.26M |